Free Trial
→ Why this tiny stock may move before the SpaceX IPO drops (From Behind the Markets) (Ad)tc pixel
NASDAQ:CERO

CERo Therapeutics Q2 2025 Earnings Report

CERo Therapeutics logo
$0.01 +0.00 (+18.18%)
As of 01:21 PM Eastern
ProfileEarnings HistoryForecast

CERo Therapeutics EPS Results

Actual EPS
-$61.71
Consensus EPS
-$70.23
Beat/Miss
Beat by +$8.52
One Year Ago EPS
N/A

CERo Therapeutics Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

CERo Therapeutics Announcement Details

Quarter
Q2 2025
Date
8/22/2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

CERo Therapeutics' next earnings date is estimated for Wednesday, September 2, 2026, based on past reporting schedules.

Conference Call Resources

CERo Therapeutics Earnings Headlines

CERo Therapeutics Announces Clinical Update from CERTAIN-T Phase 1 CER-1236 Trial, Including Patient Undergoing Allogeneic Stem Cell Transplant Following Treatment
June 15 at 8:15 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/15/3311767/0/en/cero-therapeutics-announces-clinical-update-from-certain-t-phase-1-cer-1236-trial-including-patient-undergoing-allogeneic-stem-cell-transplant-following-treatment.html
CERo Therapeutics Raises Funding via Convertible Note Financing
May 29, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/cero-therapeutics-raises-funding-via-convertible-note-financing?utm_source=marketbeat.com&utm_medium=referral
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.tc pixel
June 15 at 1:00 AM  |  Reagan Gold Group (Ad)
CERo Therapeutics Holdings Inc. Wt
May 20, 2026  |  barrons.comhttps://www.barrons.com/market-data/stocks/cerow/stock-grader
CERo Therapeutics Completes Second Ascending Dose Cohort of Phase 1 CER-1236 Trial
May 11, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/11/3291858/0/en/cero-therapeutics-completes-second-ascending-dose-cohort-of-phase-1-cer-1236-trial.html
CERo Therapeutics Secures Convertible Note Financing Facility
April 14, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/cero-therapeutics-secures-convertible-note-financing-facility?utm_source=marketbeat.com&utm_medium=referral
See More CERo Therapeutics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like CERo Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on CERo Therapeutics and other key companies, straight to your email.

About CERo Therapeutics

CERo Therapeutics (NASDAQ:CERO), an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.

View CERo Therapeutics Profile
Earnings Tools